| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 11.387 | 16.294 | 43.849 | 0 | 0 | 0 | - | - | - | - |
| Total Income - EUR | 11.387 | 22.228 | 44.140 | 16 | 5.017 | 0 | - | - | - | - |
| Total Expenses - EUR | 8.408 | 26.630 | 46.939 | 8.502 | 8.943 | 0 | - | - | - | - |
| Gross Profit/Loss - EUR | 2.980 | -4.402 | -2.799 | -8.486 | -3.926 | 0 | - | - | - | - |
| Net Profit/Loss - EUR | 2.638 | -4.879 | -3.238 | -8.486 | -4.092 | 0 | - | - | - | - |
| Employees | 2 | 1 | 2 | 1 | 1 | 0 | - | - | - | - |
Check the financial reports for the company - Ric Farma Group 2 Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 11.427 | 9.671 | 7.270 | 4.941 | 0 | 0 | - | - | - | - |
| Current Assets | 11.928 | 14.782 | 18.168 | 13.890 | 18.611 | 18.258 | - | - | - | - |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
| Receivables | 11.253 | 14.737 | 17.715 | 11.154 | 15.955 | 15.653 | - | - | - | - |
| Cash | 674 | 45 | 453 | 2.736 | 2.656 | 2.606 | - | - | - | - |
| Shareholders Funds | 2.683 | -2.223 | -5.424 | -13.810 | -17.635 | -17.301 | - | - | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | - | - | - | - |
| Debts | 20.672 | 26.677 | 30.862 | 32.641 | 36.246 | 35.559 | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4941 - 4941" | |||||||||
| CAEN Financial Year |
4941
|
|||||||||
Comments - Ric Farma Group 2 Srl